Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Rexahn's Human Data Confirms Anti-Cancer Advantage
Rexahn's Human Data Confirms Anti-Cancer Advantage
Rexahn's Human Data Confirms Anti-Cancer Advantage
Submitted by
admin
on September 30, 2015 - 9:41am
Source:
Yahoo
News Tags:
Rexahn
RX-3117
Supinoxin
cancer
Headline:
Rexahn's Human Data Confirms Anti-Cancer Advantage
Do Not Allow Advertisers to Use My Personal information
